Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Sleep Med. 2012 Aug 23;13(10):1307–1312. doi: 10.1016/j.sleep.2012.07.002

TABLE 4.

Polycystic Ovary Syndrome Sub-analysis

PCOS
with OSA
(n=16)
PCOS
without OSA
(n=12)
P value
Age (yrs) 16.8 ± 2.1 16.6 ± 1.7 0.8
1BMI Z-score 2.5 ± 0.3 2.3 ± 0.5 0.1
Metformin (n) (%) 5 (31.3%) 5 (41.6%) 0.6
Oral contraceptives (n) (%) 3 (18.8%) 3 (25%) 0.7
Adenotonsillectomy (n) (%) 6 (37.5%) 3 (25%) 0.5
Free testosterone (pg/ml) 9.7 ± 4.2 7.6 ± 4.5 0.3
Total testosterone (ng/dl) 54.2 ± 30.1 51.0 ± 23.3 0.2
2MetS (n) (%) 9 (56.3%) 1 (8.3%) 0.03
3HOMA-IR>4 13(81.3 %) 5 (41.6%) 0.03
Fasting glucose (mg/dl) 99.3 ± 21.3 88.2 ± 8.9 0.07
Fasting insulin (IU) 8.4 ± 5.5 5.3 ± 3.6 0.09
Fasting TG (mg/dl) 149.7 ± 87.7 93.3 ± 25.8 0.03
Fasting HDL (mg/dl) 38.6 ± 8.7 49 ± 10.9 0.01
Systolic blood pressure (mmHg) 128.4 ± 12.8 115.6 ± 11.4 0.009
Diastolic blood pressure (mmHg) 71.4 ± 0.4 67.8 ± 11.5 0.4

Data represented as mean ± SD

1

Body mass index Z-score

2

MetS; metabolic syndrome based on Weiss criteria (21)

3

HOMA-IR; fasting glucose (mg/dL) × fasting insulin (μU/mL)/405